Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: RoadyHD who wrote (12541)	12/14/2019 2:12:19 PM
From: BoredMember	Read Replies (1) \| Respond to of 12873

In my opinion, there is absolutely no reason for Dr. Anil Diwan to do why you are suggesting. It would be much more beneficial for him to let the money run out and get the lab for himself and sell it. There is zero value in the virocides as they are not legitimate. Sure he may face a few lawsuits, but he has done just enough to make it appear he was moving towards drug development in good faith and he has the “speculative investment” boilerplate language in all releases and filings. He and Dr. Eugene Seymour and their families have made 10’s of millions from this scam. He’ll either let it go bankrupt and get out “clean” or it will float down to pennies and be a zombie stock for years. But boy, they sure had a great ride while it lasted! (BUT...if he thinks he can milk this for more money by doing one more round of poison financing that will benefit him, I am confident he will do it...stockholders be damned)

To: RoadyHD who wrote (12541)	12/14/2019 5:12:04 PM
From: mattstat	Respond to of 12873

I am no longer confident about any prospects with this firm due to Diwan's mishandling. So at this point, I say let Rome burn. I will lose it all, so why should Diwan continue to make $450 K from this disaster. I say let it all come crashing down now. Too many promises, and no deliverable were ever met. To Seymour and Diwan and the whole gang, I'm done! I'm burned out and fed up, and will vote NO on any further compromises!

To: RoadyHD who wrote (12541)	12/14/2019 9:59:03 PM
From: HardToFind	1 Recommendation Recommended By mattstat Read Replies (1) \| Respond to of 12873

NNVC's licensing deals with TheraCour would be acceptable and reasonably attractive if NNVC were a BP (hence the supposed "fair" opinions) with lots of cash and capital and a distribution channel. I would argue the 15% royalty rate might be fair IF...and it's a big IF...if TheraCour had taken all of the development risk through Phase II. As we're all well aware, NNVC has risked and lost $100 Mn at the hands of Diwan, largely on licensed drug development that has so far proven worthless. And yet, having risked little to nothing until he spent all of NNVC's money, Diwan thinks he deserves $9 Mn (plus what he has recently lent the company), in addition to a 15% royalty. Given the circumstances, I disagree about the acceptability and attractiveness, even for a Big Pharma. I think they would demand better terms from Diwan, which is why, from the beginning, Diwan pulled the deceptive shenanigans that caused Yidam to sue. If it were fair, he could have dealt honestly with shareholders from the beginning. He didn't do that.